Repaglinide |
Repaglinide : Inhibitor of ABCC8, KCNJ11
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| ABCC8 |
|
|
| KCNJ11 |
|
|
Inhibitor
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50 - SLC22A1: 9,200 nM
Potency Assay Off-Target:
Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK29 ...
Selectivity Assessment Description:
Inactive against CYP3A4, CYP2C8 and CYP3A5; data from ChEMBL and Probe Miner (http://probeminer.icr. ...
Potency Cellular
In Vitro
ABCC8
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.2337/diabetes.51.9.2789
KCNJ11
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.2337/diabetes.51.9.2789
In Vivo Validations
Rat
Dose: 1 mg/kg
Route of delivery:
Oral
Organ of interest (O):
Pancreas
Target engagement assay:
Indirect; repaglinide decreased blood glucose with an ED50=15.6 ug/kg.
DOI Reference: 10.1016/j.bmcl.2004.07.059
Orthogonal Probes def
Glyburide
Chemical Information
| Molecular Formula | C27H36N2O4 |
| SMILEs | CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O |
| InChI | InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1 |
| Molecular weight | 452.27 Da |
| AlogP | 0.0 |
| HBond acceptors | 6 |
| HBond donors | 2 |
| Atoms | 69 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.